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Systemic Colchicine Inhibits Goldfish Optic Nerve Regeneration. DAVIS, R. E., SCHLUMPF, 
B. E., AND KLINGER, P. D. (1984). Toxicol. Appl. Pharmacol. 73, 268-274. Experiments were 
carried out to further investigate the regenerating goldfish optic nerve as a preparation for screening 
drugs or environmental toxins for adverse effects on neuronal circuit development. Regeneration 
was induced by unilateral retrobulbar optic nerve crush, and the opposite eye was kept intact. 
The time to recovery of vision was measured, as an index of regeneration and neurotoxicity, by 
an improved behavioral technique. The visual stimulus was changed to eliminate extraretinal 
photoresponding and to permit testing for vision with the right or left eye independently in a 
trial. Visual recovery occurred within 14 to 25 days. Colchicine, a potent inhibitor of microtubules 
and axonal transport, was administered semiweekly by ip injection, as in earlier experiments, 
to study the efficacy of the protocol. The drug resulted in an inhibition of regeneration at doses 
up to 0.2 erg/g body wt which did not impair responding with the control eye. Administration 
of @-lumicolchicine, a photoisomer of colchicine that is a weak inhibitor of microtubules or 
axonal transport, up to 2.0 pg/g body wt, had no effect on regeneration or maintenance of visual 
responding. The results support the thesis that regenerating circuits are more sensitive indicators 
of neurotoxicity than arc established circuits and confirm that the regenerating optic nerve can 
be used to screen molecules that may impair neuronal circuit development in vivo and to measure 
their relative potency. 
Previous experiments by our laboratory 
showed that the regenerating goldfish optic 
nerve may be a promising preparation for 
screening molecules for adverse effects on 
neuronal circuit development in viva (Davis 
and Benloucif, 198 1). A protocol was inves- 
tigated in which regeneration is induced by 
crushing the optic nerve within the orbit near 
the eyeball (Attardi and Sperry, 1963: Graf- 
stein and McQuarrie, 1978; Springer and 
Agranoff, 1977). Neurotoxicity atTecting ax- 
onal regeneration or the recovery of visual 
function in the retinal ganglion cells is assessed 
by measuring the time to recovery of vision. 
Visual recovery time is measured by a classical 
’ Supported by the U.S. Environmental protection 
Agency under Grant 808064-02. 
conditioning technique in which a branchial 
suppression response (SR) to a light condi- 
tioned stimulus (CS) serves as the response 
index of vision. The efficacy of the protocol 
was examined with the alkaloid neurotoxins, 
colchicine and vincristine sulfate (Ochs, 1974, 
Banks and Till, 1975; Dahlstrom et al., 1975; 
Hanson and Edstrom, 1978), which were ad- 
ministered intraperitoneally twice weekly for 
3 weeks following optic nerve crush or a sham 
operation. Colchicine and vincristine each in- 
hibited recovery of the SR in optic nerve crush 
fish at systemic concentrations that did not 
impair maintenance of response in sham-op- 
erated fish which indicates that the behavioral 
protocol can detect an inhibition of optic nerve 
regeneration produced by systemically ad- 
ministered drugs. However, the study was 
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complicated by the finding that the SR could Experimental drugs. Colchicine and fl-lumicolchicine 
be evoked by extraretinal, as well as retinal, (Sigma) were administered ip by a 30-gauge needle and 
cues produced by the CS (Davis and Benloucif, 
a 100~~1 Hamilton syringe (Davis and Benloucif, 198 1). 
198 1). Because extraretinal SRs might produce 
Colchicine was delivered in 0.15 M NaCl and lumicol- 
chicine in PET-80 which consisted of 3% ethanol, 3% 
errors in assessing the time to recovery of vi- Tween-80, and propylene glycol. The drug was dissolved 
sion. the orotocol was revised (Davis and in the ethanol and Tween-80 at approximately 60°C prior 
Schlumpf, ‘1983). 
The present experiments were carried out 
to reassess the toxicity of colchicine by the 
revised behavioral assay. In the original pro- 
tocol, one eye was removed from every fish 
prior to SR conditioning and the CS consisted 
of a change-of-luminance CS, that is “on-off,” 
that was produced by turning on a bright light 
in darkness. The revised protocol employs a 
moving-spot-of-light CS which avoids the 
problem of extraretinal photostimulation 
(Davis and Schlumpf, 1983). The moving-spot 
CS is presented monocularly so that one eye 
can be used as the experimental, to detect 
drug effects on recovery of vision, and the 
other as a control, to detect effects of mainte- 
nance of response. Treatments that inhibit vi- 
sual recovery after optic nerve crush but do 
not inhibit maintenance of response with the 
control eye can be inferred to inhibit optic 
axon regeneration. 
METHODS 
Fish. Goldfish (Carassius aura&s L.), 8 to 12 g, obtained 
from Ozark Fisheries, Stoutland, Missouri, were kept in 
large tanks at 26 to 28°C for several weeks prior to being 
placed in individual home tanks at 30°C. Fish were fed 
Tetramin conditioning flake food once or twice daily. The 
daily photoperiod was 16:8 hr L:D with fluorescent light 
augmented by diffuse natural light. The tank water was 
a mixture of distilled and charcoal filtered, softened well 
water; the conductivity was 450 + 50 mmho/cm and the 
pH was 7.0-7.5. Experiments were conducted during Jan- 
uary through May. 
Surgery. To crush the optic nerve, hsh were. anesthetized 
by immersion in 0.04% trimethanemethylsulfonate 
(Sigma) in tank water buffered with Tris 8sh buffer (Sigma) 
to pH 6.5-7.5, wrapped in a moist paper towel, and pIaced 
on the stage of a microscope. The eyeball was rotated 
ventrally and the nerve was exposed through a slit that 
was cut in the conjunctiva dorsal to the eye. The nerve 
was crushed by pinching it twice with a Dumont No. 7 
forcep. The anesthetized fish was returned to the home 
tank to recover. 
to dilution with propylene glycol. The volume of each 
injection was 1 PI/g body wt. 
Conditioning tank and stimuli. Fish were conditioned 
individually in three glass tanks which were 15 cm wide, 
15 cm deep, and 30 cm long and filled with 8 cm of water 
heated to 30 r 05°C. The fish was restrained in a holder 
5 cm beneath the surface of the water in the center of the 
tank and 45 cm beneath two 20-W, cool-white fhiorescent 
lamps which were continuously illuminated, and the fish’s 
branchial movements were detected by a thermistor. The 
CS consisted of the flickering movement of a spot of red 
light, which was produced by alternately illuminating two 
light-emitting diodes (LEDs, 4-mm diam; General In- 
strument, MV 5732) that were centered one above the 
other 1 cm apart. Similar pairs of LEDs were submerged 
in the water opposite each eye. The upper LED was ap 
proximately 2.5 cm from the eye and 1 cm below its 
horizontal axis and the angle of view subtended by the 
spot of light was IO”. The lower LED was kept lit during 
the intertrial interval. During the CS interval, the upper 
and lower LED were illuminated alternately every 250 
msec. This procedure produced movement of the spot of 
light through an angle of 26”. The unconditioned stimulus 
(US) was a 0.25~set pulse from 7- to 8-mA (RMS), 60- 
Hz constant current that was passed between two steel 
electrodes on opposite sides of the fish holder (Davis, 198 1; 
Davis and Schlumpf, 1983). 
Preliminary conditioning. Fish were administered two 
or three semiweekly sessions of conditioning trials. Each 
session consisted of twenty 2-set CS-US trials, followed 
by four 5-set CS-US test trials. The CS was turned on 
for 2 or 5 set and the US was presented at the instant 
that the CS was terminated. The 2-set trials were initiated 
automatically by a microprocessor at random intervals of 
0.5 to 3 min in duration and the fish’s response to the 
CS was not recorded. The CS was presented to the right 
(R) or left (L) eye in pseudorandom order. The SR to the 
CS was recorded in the 5-set trials, which were initiated 
by the investigator at times when the fish’s branchial 
movements were regular, and the branchial beat rate was 
measured by a tachograph method (Davis and Schlumpf, 
1983). A microprocessor counted the number of branchial 
beats during the 5-set interval (B) of the test trial, and 
the number during the 5-set interval (A) preceding the 
onset of the trial and calculated the percentage change in 
the rate in interval B relative to the rate in A [100X (1 
- B/A)] which is noted as the SR. A SR of greater than 
30% was accepted as a response indicative of vision. Fish 
that responded in R- and Ltriab were retained as potential 
subjects (Davis and Schlumpf, 1983). 
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Preoperative test sessions. Within a week prior to an 
experiment, potential subjects received a test session con- 
sisting of four 2-set trials (order: RLRL) followed by four 
5-set test trials (RLRL). The occurrence of false-positive 
responses was assessed in blank trials administered prior 
to each test trial. Fish that responded to the CS (SR greater 
than 30%) in each of the four test trials and showed no 
false positives were accepted as subjects. 
Assay protocol and data analysis. Subjects received right 
optic nerve crush and ip administration ofeither colchicine, 
lumicolchicine, saline, or PET-SO. The left optic nerve 
was kept intact. The drugs were administered the day 
before surgery and following each postaxotomy test session. 
The day of optic nerve crush was designated as Day 0, 
and test sessions were given twice weekly beginning at 4 
days postaxotomy (DPA). The procedure in each session 
was the same as in the preoperative test session. 
The data for each session were reduced by computing 
the average SR (percentage suppression) in R- or L-trials 
for each fish. The effects of the various doses of colchicine 
on the mean SR were analyzed initially in an ANOVA 
for one grouping factor, Dose, with two within factors, 
Day (4,7, . .) and Eye (R, L). Between-group dilherences 
in recovery of vision were further evaluated by the ratio 
of the average SR in R-trials to the average SR in L-trials, 
which is designated as the Sightedness (5’) score. The mean 
S scores of the various groups were contrasted in an AN- 
OVA for one grouping factor, Dose, with one within factor, 
Day. BMDP statistical software was used (Dixon et al., 
1981). 
The 50% effective dose (ED50) was defined as the dose 
that is estimated to produce a mean S score of 0.5 on 21 
DPA. The 21-day time point was taken as an approxi- 
mation of the time following axotomy when the mean S 
score for control fish approaches unity. The 2 1 -day ED50 
and 95% confidence limits were derived from the regmssion 
of the mean S score against the log of the dose + 1. 
RESULTS 
Colchicine inhibited visual recovery in- 
creasingly with the dose up to 0.2 pg/g body 
wt which was the highest dose tested (Fig. 1). 
The ANOVA on the mean S score for the 
saline and the colchicine groups revealed sig- 
nificant Dose [F(4,32) =. 5.12, p < 0.011 and 
Day [F(6,192) = 45.53, p < 0.011 effects and 
a Dose X Day interaction [F(24,192) = 3.93, 
p < 0.011. Three fish receiving 0.2 pg/g died, 
one at 11 DPA and two at 18 DPA, and their 
data were omitted. The 2 l-day ED50 was 0.08 
(0.06 to 0.10) &g. 
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FIG. 1. Effects of ip administered colchicme on recovery 
of R-eye sightedness (S score) following R-optic nerve 
crush, Mean S scores of less than 0.05 were not plotted. 
Whether colchicine impaired maintenance 
or only recovery of response was determined 
by examining the effects of Dose or Day on 
the mean SR in L- or R-trials (Eye factor). 
The primary ANOVA showed significant Dose 
[F(4,32) = 2.81, p -C 0.051, Eye [F( 1,32) 
= 833.34, p < 0.011, and Day [F(6,192) 
= 35.08, p < 0.011 effects and Dose X Eye 
X Day interaction [F(24,192) = 3.59, p 
< 0.011. An ANOVA on the R-trial data 
showed significant Dose [F(4,32) = 4.92, 
p< 0.011 and Day [F(6,192) = 45.52, p 
< 0.011 effects and Dose X Day interaction 
[F(24,192) = 3.79, p < 0.011. In contrast, the 
mean SR in Gtrials was unaffected by Dose 
[F(4,32) = 1.24 p > 0.31 or Day [F(6,192) 
= 1.62, p > 0.31. Thus, there was no evidence 
of an effect on maintenance of response to 
the CS. 
Lumicolchicine e&c& Fish administered 
p-lumicolchicine, 0.2 or 2.0 &g body wt, sa- 
line, or PET-80 without a drug showed no 
significant differences in recovery of R-eye 
sightedness [fl18,180) = 1.40, p > 0.11 (Fig. 
2). The groups showed uniformly high levels 
of response in Gtrials and the recovery of the 
mean SR in R-trials closely paralleled the 
mean S score. ANOVAs on the mean SR for 
the four groups revealed significant Eye 
[F( 1,29) = 526.74, p < 0.011 and Day 
[F(6,174) = 89.69, p < 0.011 effects and an 
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FIG. 2. Effects of ip administered /34umicolchicine or 
saline or PET-80 on recovery of R-eye sightedness (S 
score) following R-optic nerve crush. Mean S scores of 
less than 0.05 were not plotted. 
Other revisions that were made which might 
produce more accurate measurements of vi- 
sual recovery time were improved water qual- 
ity and more uniform temperatures in the 
home tank and the experimental tank, a more 
objective method of measuring the branchial 
SR, and the use of a within-fish, rather than 
between-fish, experimental design to dissociate 
drug effects on recovery and maintenance of 
response. The difference in the dose-response 
curves obtained with the original and the re- 
vised protocols does not appear to be a result 
of using the mean S score, instead of the per- 
centage-of-fish responding, as the measure of 
visual recovery (Fig. 3). 
Mode of Action of Colchicine 
Eye X Day interaction [fl6,174) = 119.85, p Colchicine is a potent inhibitor of micro- 
< 0.011. Day affected the mean SR in R-trials tubules and axonal transport (Ochs, 1974; 
[F(6,180) = 115.5, p < 0.011 but not L-trials Paulson and McClure, 1975; Hanson and Ed- 




Improved Measure of Drug Efect on Optic 
Nerve Regeneration 
This investigation conlirms and extends the 
earlier report (Davis and Benloucif, 198 1) that 
the time to recovery of a branchial SR to a 
conditioned visual CS can be used to measure 
the effects of systemically administered mol- 
ecules on optic nerve regeneration. The revised 
protocol detected effects of colchicine at doses 
lower than the original as can be seen in Fig. + 
3. The key revision may be in the CS, namely, 
changing the on-off CS, which might have 
evoked extraretinal SRs during the postaxo- 
tomy period prior to visual recovery, to the 
more refined moving-spot CS that does not 
evoke the SR extraretinally (Davis and 
Schlumpf, 1983; unpublished data). Extrare- 
tinal SRs would result in an underestimation 
of visual recovery time and, thereby, the tox- 
icity of colchicine to regenerating optic axons. 
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FIG. 3. Colchicine dose-response curves for the original 
and revised protocols. Curve A is the regression of the 
dose against the percentage of fish responding (SR > 30%) 
at 17 DPA in the original protocol. Curves B and C show 
the regression of the dose against, respectively, the per- 
centage of fish responding or the mean S score (X100) 
on 2 1 DPA in the revised protocol. The vertical intersects 
denote the ED50 which was calculated to be 0.17 (0.15 
to 0.18) Icplg body wt for A, 0.09 (0.06 to 0.1 I) pg/g for 
B, and 0.08 (0.05 to 0.10) pgJg for C. 
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Strom, 1978) which are essential for neuronal 
growth and development (Grafstein, 1975; 
Grafstein and Foreman, 1980) and for the 
maintenance of function in established neu- 
ronal circuits (Perisic and Cuenod, 1972). The 
inhibitory effects of colchicine and other al- 
kaloid antimitotic drugs have been the main 
evidence that microtubules participate in ax- 
onal transport. These alkaloids have a high 
affinity for tubulin, the subunit protein of mi- 
crotubules, which suggests that they may 
compete with endogenous inhibitors of mi- 
crotubule polymerization (Sherline et al., 
1979) but they also bind to other axoplasmic 
proteins and membranes and are thus not 
specific inhibitors of microtubules (Feit and 
Barondes, 1970). 
suggests that systemic colchicine inhibits visual 
recovery, at least in part, by inhibiting mi- 
crotubules or axonal transport. 
CS-Related Differences in Visual Recovery 
Time 
Colchicine taken up into retinal ganglion 
cells of the experimental eye could inhibit ax- 
onal outgrowth to brain visual centers or the 
formation of synaptic connections between the 
incoming optic axons and their targets. Axonal 
sprouting (Hoffman, 1952) peripheral nerve 
fiber regeneration (Mellick et al., 1974), and 
neurite outgrowth in vitro (Daniels, 1972) are 
reported to be inhibited by colchicine. Ex- 
periments in pigeons showed that synaptic 
transmission in optic axons was decreased fol- 
lowing an intraocular injection of colchicine 
that inhibited axonal transport (Perisic and 
Cuenod, 1972), but effects on vision were not 
reported. Axonal transport in trout optic nerve 
was inhibited following a single intraocular 
administration of approximately 1 but not 0.5 
pg/g body wt colchicine (Schonhartung et al., 
1977). 
Our experiments provide the first evidence 
that the time to recovery of a response, in this 
case a conditioned branchial SR, varies with 
the properties of the visual stimulus. Other 
laboratories have demonstrated that recovery 
time varies between protocols with different 
responses and stimuli. For example a whole- 
body photic startle response to sudden over- 
head illumination (Edwards et al., 198 1) reap- 
pears in 1 to 2 weeks; an unconditioned bran- 
chial SR to an overhead shadow (Springer and 
Agranoff, 1977) and a conditioned branchial 
SR to a relatively bright on-off CS (Davis and 
Benloucif, 198 1) reappear within 2 to 3 weeks; 
and a whole-body pursuit response to a mov- 
ing visual field is restored several weeks later 
(Springer and Agranoff, 1977). 
Control nerve crush fish showed initial re- 
covery of the branchial SR to the on-off CS 
of the original protocol within 17 DPA and 
to the moving-spot CS within 25 DPA. The 
increased time to recovery suggests that the 
neuronal regeneration processes involved may 
differ. Detection of the moving-spot CS might 
require a more extensive restoration of the 
retinotectal system and, thereby, a longer pe- 
riod of recovery (Springer and Agranoff, 1977) 
or the completion of recovery processes within 
retinal ganglion cells (Edwards et al., 1981) 
or within postsynaptic neurons that are not 
required for detection of the on-off CS. The 
conclusion that the time to recovery of the 
SR is stimulus dependent is supported by a 
pilot study with a different stimulus. We had 
planned to use a moving-ring CS which em- 
ployed “linear” instead of “spot” light-emit- 
ting diodes (Davis and Schlumpf, 1983) but 
recovery times were 7 to 10 days longer than 
for the moving-spot CS, and the latter was 
Lumicolchicine is a photoisomer of col- 
chicine that binds to various axoplasmic pro- 
teins but, in contrast to colchicine, has a very 
low affinity for tubulin (Banks and Till, 1975) 
and is a correspondingly weak inhibitor of 
microtubule assembly or axonal transport 
(Dahlstrom et al., 1975; Hanson and Edstrom, 
1978). Systemic concentrations up to 2 pg/g 
body wt lumicolchicine, which is 25 times the 
ED50 for colchicine, had no effect on visual 
recovery. The ineffectiveness of lumicolchicine adopted for experimental efficiency. 
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Dissociation qfRegeneration and Maintenance 
Eflects 
The fact that colchicine inhibits recovery 
of response at systemic doses below those that 
inhibit maintenance of response in the same 
individual supports the thesis that regenerating 
or developing neuronal circuits may be more 
effective indicators of neurotoxicity than are 
mature or established circuits (Davis and Ben- 
loucif, 198 1). Systemic doses of colchicine that 
inhibit optic nerve regeneration are presum- 
ably toxic to normal retinal and other neurons 
and to many other types of cells throughout 
the body. Several fish receiving the 0.2 pg/g 
dose died during experiments and increasing 
the dose to 0..3 pg/g is lethal to most individ- 
uals in 21 days. 
The possibility that colchicine was unevenly 
distributed in the experimental and control 
optic systems needs to be considered. Since 
the blood-brain barrier may normally exclude 
most systemic colchicine (Bennett and Alberti, 
198 1) and crushing the optic nerve ruptures 
the barrier (Kiernan and Contestabile, 1980) 
there may be greater uptake in the experi- 
mental as opposed to the control optic system. 
Drugs taken up in the experimental optic 
nerve would presumably diffuse into other 
brain structures including visual centers that 
mediate control eye responding. While ad- 
ditional experiments are needed to clarify 
whether the blood-brain barrier could be re- 
sponsible for the greater effect of colchicine 
on regenerating, as opposed to normal optic 
axons, the procedure of testing for regenera- 
tion and maintenance effects in the same in- 
dividual is an improvement over the original 
between-fish design. 
In conclusion, our results indicate that the 
time to visual recovery following optic nerve 
crush can be used to screen molecules for ad- 
verse effects on neuronal circuit development. 
The assay has several important features. Drug 
effects are assessed at the cellular level in a 
well-known and anatomically localized pop 
ulation of neurons, the retinal ganglion cells, 
in viva. Regenerating optic axons may be more 
sensitive indicators of neurotoxicity than are 
mature axons and, therein, better suited for 
detecting sublethal toxicity. The assay should 
be sensitive to molecules that inhibit (or pro- 
mote) neuronal metabolism, biosynthesis, ax- 
onal transport, or any aspect of neuronal fiber 
development or synapse formation. Optic 
nerve regeneration is a pathological prepa- 
ration but it seems reasonable to assume that 
it includes many cellular processes that occur 
during normal neuronal circuit development. 
Thus, evidence that a drug inhibits optic nerve 
regeneration would strongly imply that it may 
be injurious to normal neurons. 
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